Putting the bio in biotherapeutics/checkpoints for biosimilars/ application of biosimilars
European Journal of Molecular & Clinical Medicine,
2016, Volume 3, Issue 3, Pages -
AbstractThe number of biosimilar medicines on the market is steadily increasing, due, in part, to patent expiration of several top-selling biologic medicines. These three e-learning modules discuss the basic concepts behind biosimilar medicines and highlight key regulatory considerations when using biosimilar medicines in medical practice.
- Article View: 16
- PDF Download: 35